A CROSS-SECTIONAL STUDY ON THE PREVALANCE AND RISK FACTORS OF LYMPHOEDEMA IN CARCINOMA BREAST

Vishnu Gopal; Abhinabha Acharya; Vasudha Narayanaswamy; Santanu Pal

doi:10.22159/ajpcr.2017.v10i6.16118

Authors

Vishnu Gopal Department of Radiotherapy, Institute of Post Graduate Medical Education and Research and Sekh Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.
Abhinabha Acharya Department of Radiotherapy, Institute of Post Graduate Medical Education and Research and Sekh Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.
Vasudha Narayanaswamy Department of Radiotherapy, Institute of Post Graduate Medical Education and Research and Sekh Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.
Santanu Pal Department of Radiotherapy, Institute of Post Graduate Medical Education and Research and Sekh Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i6.16118

Keywords:

Breast cancer, Radiotherapy, Lymphedema

Abstract

Objectives: Lymphedema of the arm is a devastating complication of breast carcinoma treatment. There is a lack of research on the risk factors and methods of preventing upper limb lymphedema after breast carcinoma treatment. The aims of the study are to identify the prevalence and risk factors for upper limb lymphedema in patients attending a tertiary cancer care center in India.

Methods: 199 patients who attended the outpatient department of radiotherapy of IPGMER and SSKM, after undergoing surgical treatment for breast cancer between November 2014 to May 2016 were examined for the presence of lymphedema and its risk factors were analyzed. Lymphedema was defined as being present when there is an increase of >5% sum difference in the arm circumferences measured at different levels of both the upper limbs.

Results: Of the 199 patients analyzed, 85 (42.7%) patients were found to have lymphedema. The prevalence of lymphedema was 25% in those who underwent surgery alone and 54% in those who underwent chest wall radiotherapy also. Locally advanced stage of the disease, body mass index >25 kg/m2, number of lymph nodes removed during surgery, and adjuvant radiotherapy were found to be significant risk factors for the development of lymphedema.

Conclusion: Based on the results of this study, we recommend weight reduction and more judicious axillary lymph node dissection and use of postoperative radiotherapy as methods to prevent breast cancer-associated lymphedema in the tertiary cancer care centers in India.

Downloads

Download data is not yet available.

Author Biography

Vishnu Gopal, Department of Radiotherapy, Institute of Post Graduate Medical Education and Research and Sekh Sukhlal Karnani Memorial Hospital, Kolkata, West Bengal, India.

DEPT OF RADIOTHERAPY

POST GRADUATE TRAINEE

References

Maunsell E, Brisson J, DeschÃªnes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36(4):315-20.

Carter BJ. Womenâ€™s experiences of lymphedema. Oncol Nurs Forum 1997;24(5):875-82.

Passik S, Newman M, Brennan M, Holland J. Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage 1993;8(4):226-33.

Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999;177(3):184-7.

Kanagathara N, Kavitha K. Evaluation of HER-2/neu over expression in breast cancer. Int J Pharm Pharm Sci 2014;6(2):898-900.

Suneson BL, Lindholm C, Hamrin E. Clinical incidence of lymphoedema in breast cancer patients in JÃ¶nkÃ¶ping County, Sweden. Eur J Cancer Care 1996;5(1):7-12.

Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991;126(11):1336-41.

SegerstrÃ¶m K, Bjerle P, Graffman S, NystrÃ¶m A. Factors that influence the incidence of brachial oedema after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg 1992;26(2):223-7.

SchÃ¼nemann H, Willich N. Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med Wochenschr 1997;122(17):536-41.

Meek AG. Breast radiotherapy and lymphedema. Cancer 1998;83 12 Suppl:2788-97.

Rockson SG. Precipitating factors in lymphedema: Myths and realities. Cancer 1998;83 12 Suppl:2814-6.

SchÃ¼nemann H, Willich N. Lymphoedema of the arm after primary treatment of breast cancer. Anticancer Res 1998;18(3C):2235-6.

Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 2007;109(10):1949-56.

Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001;92(7):1783-7.

Lakshmi R, Vijayalakshmi S, Raju A, Joy TM. Assessment of various risk factors of breast cancer. Asian J Pharm Pharm Sci 2013;5(4):675-8.

Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, et al. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer 2004;41(10):8-12.

Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst 2001;93(2):96-111.

Pain SJ, Purushotham AD. Lymphoedema following surgery for breast cancer. Br J Surg 2000;87(9):1128-41.

Margaret LF. Lymphedema. In: Berger AM, Portenoy RK, Weissman DE, editors. Principles and Practice of Supportive Oncology. New York: Lippincott-Raven; 1998. p. 275-89.

Fisher B, Montague E, Redmond C, Deutsch M, Brown GR, Zauber A, et al. Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1980;46(1):1-13.